OR WAIT null SECS
August 12, 2021
Lonza and Sheba Medical Center have successfully dosed four patients with a CD19 autologous CAR-T cell therapy using Lonza’s Cocoon automated manufacturing platform.
Moderna will build an mRNA vaccine manufacturing facility in Canada to provide access to domestically manufactured vaccines against respiratory viruses.
The Just - Evotec Biologics facility in Redmond, Wash., uses the company’s J.POD technology.
The EC has approved the drug in the EU for treatment of chronic kidney disease in adults with or without type-2 diabetes.
Nobelpharma has come to terms on an agreement to use ProBioGen’s vaccine manufacturing platform AGE1.CR.plX.
August 11, 2021
The MHRA has approved GW Pharmaceuticals’ Epidiolex for the treatment of seizures associated with tuberous sclerosis complex.
Datwyler offers the StarterPack packaging system designed to aid in the development of parenteral drug packaging.
August 10, 2021
The agency is endorsing recommendations for global track-and-trace systems developed by the International Coalition of Medicines Regulatory Authorities.
August 09, 2021
Kyowa Pharmaceutical Industry and Bora Pharmaceuticals have announced a partnership to produce generic-drug product for filing in Japan.
Emergent BioSolutions has been granted approval from FDA to ship certain lots of their AstraZeneca vaccine.